Comprehensive analysis of hormone replacement therapy and breast cancer risk, including research findings, clinical implications, and alternative treatments.
Breakthrough in triple-negative breast cancer treatment using LHRH peptide-decorated cross-linked micelles for targeted drug delivery
Exploring how short-term, high-dose estrogen exposure can permanently reprogram mammary tissue to resist carcinogenesis while long-term exposure increases risk.
Exploring the molecular interplay between estrogen receptors and growth factors in breast cancer development and treatment resistance.
Discover how SCN3B, a voltage-gated sodium channel subunit, acts as a powerful metastasis suppressor in breast cancer by inhibiting cell migration and invasion.
Exploring how estrogen pellets in lab mice may be distorting breast cancer research and potential solutions for more accurate modeling.